Oh Soo Young, Park Jung Yun, Yang Kwan Mo, Jeong Seong-A, Kwon Yong Jae, Jung Yun Tae, Ma Chung Hyeun, Yun Keong Won, Yoon Kwang Hyun, Kwak Jae Young, Yu Chang Sik
Department of Surgery, Yeouido St. Mary's Hospital, College of Medicine, The Catholic University of Korea, Seoul, Republic of Korea.
Department of Surgery, Gangneung Asan Hospital, University of Ulsan College of Medicine, Gangneung, Republic of Korea.
BMC Gastroenterol. 2025 Apr 20;25(1):276. doi: 10.1186/s12876-025-03882-3.
Octogenarians constitute a growing number of diagnoses for colorectal cancer. However, the optimal treatment for these increasingly vulnerable octogenarians with colorectal cancer remains a challenging issue. The aim of this study was to evaluate the oncologic outcomes of colorectal cancer, comparing octogenarians (> 80 years) and younger age (60-79 years).
A total of 657 patients underwent surgery for colorectal cancer between January 2015 and December 2019 at Gangneung asan hospital. Among them, 444 patients over the age of 60 were enrolled. The exclusion criteria were as follows: only local resection, R1 and R2 resection, Stage IV, absence of data in follow-up, concurrent inflammatory bowel disease, concurrent malignancy, and prior history of malignancy. The patients were divided into two groups according to their age: Octogenarian group (OG, aged > 80 years, n = 83), and younger group (YG, aged 60 to 79 years, n = 361). Inverse probability of treatment weight (IPTW) was used to control for confounding factors.
We used Inverse Probability of Treatment Weighting (IPTW) to control confounding factors and ensure a balanced comparison between octogenarians (OG) and younger patients (YG). Before IPTW adjustment, the OG had significantly worse 3-year overall survival (90.0% vs. 78.6%, p = 0.045), while 3-year disease-free survival (DFS) was similar between YG and OG (87.8% vs. 83.6%, p = 0.349). Additionally, the OG had a higher rate of emergency surgery (21.7% vs. 11.4%, p = 0.020), higher ASA classification (≥ III in 66.3% vs. 48.8%, p = 0.006), higher overall mortality (43.4% vs. 21.9%, p < 0.001), and less frequent use of adjuvant chemotherapy (17.2% vs. 57.6%, p < 0.001). Multivariate analysis showed that older age (hazard ratio [HR] = 2.177, 95% confidence interval [CI]: 1.452-3.264, p < 0.001), emergency surgery (HR = 1.831, 95% CI: 1.157-2.897, p = 0.010), severe postoperative complications (Clavien-Dindo III-V. HR = 1.357, 95% CI: 1.035-1.779, p = 0.027), higher TNM stage (stage III, HR = 5.143, 95% CI: 2.009-13.167, p < 0.001), and presence of perineural invasion (HR = 1.588, 95% CI: 1.058-2.385, p = 0.026) were significant predictors of worse survival. Similarly, independent factors associated with recurrence included emergency surgery (HR = 2.653, 95% CI: 1.550-4.542, p < 0.001), poor tumor differentiation (HR = 2.842, 95% CI: 1.198-6.743, p = 0.018), higher TNM stage (stage III, HR = 7.826, 95% CI: 2.355-26.016, p < 0.001), and presence of perineural invasion (HR = 1.876, 95% CI: 1.152-3.055, p = 0.011). However, age was not an independent factor associated with recurrence. In the subgroup analysis, the OG group with no or mild complications (Clavien-Dindo classification I-II) had a significantly better 3-year OS compared to those with severe complications (87.7% vs. 37.5%, p = 0.002). After IPTW adjustment, there were no significant differences in OS (73.2% vs. 77.5%, p = 0.120) or DFS (87.2% vs. 87.5%, p = 0.863) between the two groups. These findings suggest that age alone is not a critical determinant of oncologic outcomes once confounding variables are controlled.
After IPTW adjustment, age was not an independent factor affecting oncologic outcomes. Instead, emergency surgery, severe complications, advanced stage, tumor differentiation, and perineural invasion were significant predictors of survival and recurrence. In the subgroup analysis, octogenarians with no or mild complications had significantly better 3-year OS than those with severe complications. These findings suggest that perioperative management and disease severity, rather than age alone, should guide treatment decisions.
八十岁及以上老人患结直肠癌的诊断数量日益增多。然而,对于这些日益脆弱的老年结直肠癌患者,最佳治疗方案仍是一个具有挑战性的问题。本研究的目的是评估结直肠癌患者的肿瘤学结局,比较八十岁及以上老人(>80岁)和较年轻患者(60 - 79岁)。
2015年1月至2019年12月期间,共有657例患者在江陵峨山医院接受了结直肠癌手术。其中,纳入了444例年龄在60岁以上的患者。排除标准如下:仅行局部切除、R1和R2切除、IV期、随访数据缺失、并发炎症性肠病、并发恶性肿瘤以及既往有恶性肿瘤病史。根据年龄将患者分为两组:八十岁及以上老人组(OG,年龄>80岁,n = 83)和较年轻组(YG,年龄60至79岁,n = 361)。采用治疗权重的逆概率(IPTW)来控制混杂因素。
我们使用治疗权重的逆概率(IPTW)来控制混杂因素,并确保八十岁及以上老人(OG)与较年轻患者(YG)之间的比较均衡。在IPTW调整前,OG组的3年总生存率显著较差(90.0%对78.6%,p = 0.045),而YG组和OG组的3年无病生存率(DFS)相似(87.8%对83.6%,p = 0.349)。此外,OG组的急诊手术率较高(21.7%对11.4%,p = 0.020),ASA分级较高(≥III级在66.3%对48.8%,p = 0.006),总死亡率较高(43.4%对21.9%,p < 0.001),辅助化疗的使用频率较低(17.2%对57.6%,p < 0.001)。多因素分析表明,年龄较大(风险比[HR] = 2.177,95%置信区间[CI]:1.452 - 3.264,p < 0.001)、急诊手术(HR = 1.831,95% CI:1.157 - 2.897,p = 0.010)、严重术后并发症(Clavien - Dindo III - V级。HR = 1.357,95% CI:1.035 - 1.779,p = 0.027)、较高的TNM分期(III期,HR = 5.143,95% CI:2.009 - 13.167,p < 0.001)以及存在神经周围侵犯(HR = 1.588,95% CI:1.058 - 2.385,p = 0.026)是生存较差的显著预测因素。同样,与复发相关的独立因素包括急诊手术(HR = 2.653,95% CI:1.550 - 4.542,p < 0.001)、肿瘤分化差(HR = 2.842,95% CI:1.198 - 6.743,p = 0.018)、较高的TNM分期(III期,HR = 7.826,95% CI:2.355 - 26.016,p < 0.001)以及存在神经周围侵犯(HR = 1.876,95% CI:1.152 - 3.055,p = 0.011)。然而,年龄不是与复发相关的独立因素。在亚组分析中,无或轻度并发症(Clavien - Dindo分级I - II级)的OG组与有严重并发症的组相比,3年总生存率显著更好(87.7%对37.5%,p = 0.002)。经过IPTW调整后,两组之间的总生存率(73.2%对77.5%,p = 0.120)或无病生存率(87.2%对87.5%,p = 0.863)无显著差异。这些发现表明,一旦控制了混杂变量,年龄本身并不是肿瘤学结局的关键决定因素。
经过IPTW调整后,年龄不是影响肿瘤学结局的独立因素。相反,急诊手术、严重并发症、晚期、肿瘤分化和神经周围侵犯是生存和复发的显著预测因素。在亚组分析中,无或轻度并发症的八十岁及以上老人的3年总生存率明显优于有严重并发症的患者。这些发现表明,围手术期管理和疾病严重程度,而非年龄本身,应指导治疗决策。